| 36641948 | Increased stroke severity and mortality in patients with SARS-CoV-2 infection: An analysis from the N3C database. | J Stroke Cerebrovasc Dis | 2023 |
| 37580146 | The Lives Lost to Inequities: Avertable Deaths From Neurologic Diseases in the Past Decade. | Neurology | 2023 |
| 37580145 | NINDS Health Equity Strategic Planning Process Overview, High-Level Recommendations, and Guide. | Neurology | 2023 |
| 37258298 | Twenty-Year Disparity Trends in United States Stroke Death Rate by Age, Race/Ethnicity, Geography, and Socioeconomic Status. | Neurology | 2023 |
| 37449423 | Prestroke and Poststroke Sulfonylurea Exposure and Functional Outcomes: A Post Hoc Analysis of the SHINE Trial. | Stroke | 2023 |
| 36852919 | Effect of Alteplase on Ischemic Stroke Mortality Is Dependent on Stroke Severity. | Ann Neurol | 2023 |
| 36543630 | Corrigendum to 'self-reported race as a social determinant of stroke risk in observational versus clinical trial datasets'. | J Stroke Cerebrovasc Dis | 2023 |
| 34826677 | Self-Reported Race as a Social Determinant of Stroke Risk in Observational Versus Clinical Trial Datasets. | J Stroke Cerebrovasc Dis | 2022 |
| 35544137 | Comparison of Bayesian vs Frequentist Adaptive Trial Design in the Stroke Hyperglycemia Insulin Network Effort Trial. | JAMA Netw Open | 2022 |
| 35786006 | Quantification of hematoma and perihematomal edema volumes in intracerebral hemorrhage study: Design considerations in an artificial intelligence validation (QUANTUM) study. | Clin Trials | 2022 |
| 36333676 | Collateral status, hyperglycemia, and functional outcome after acute ischemic stroke. | BMC Neurol | 2022 |
| 34850002 | The iTHRIV Commons: a cross-institution information and health research data sharing architecture and web application. | J Am Med Inform Assoc | 2022 |
| 34649872 | Acute Ischemic Stroke Interventions in the United States and Racial, Socioeconomic, and Geographic Disparities. | Neurology | 2021 |
| 34517768 | Cilostazol for Secondary Stroke Prevention: History, Evidence, Limitations, and Possibilities. | Stroke | 2021 |
| 34455821 | Effect of Adjusting for Baseline Stroke Severity in the National Inpatient Sample. | Stroke | 2021 |
| 34455151 | Black Patients with Ischemic Stroke and Hyperglycemia have Worse outcome than Whites if given Intensive Glucose Control. | J Stroke Cerebrovasc Dis | 2021 |
| 32078476 | Fully Automated Segmentation Algorithm for Perihematomal Edema Volumetry After Spontaneous Intracerebral Hemorrhage. | Stroke | 2020 |
| 31060438 | Crucial Role of Women's Leadership in Academic Stroke Medicine. | Stroke | 2019 |
| 31712367 | Statins for neuroprotection in spontaneous intracerebral hemorrhage. | Neurology | 2019 |
| 31821427 | Treatment of Hyperglycemia in Patients With Acute Stroke-Reply. | JAMA | 2019 |
| 31334795 | Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial. | JAMA | 2019 |
| 30738650 | Considering prehospital stroke trials: did RIGHT-2 get it right? | Lancet | 2019 |
| 28751554 | Translational Stroke Research: Vision and Opportunities. | Stroke | 2017 |
| 26896433 | Suspected Large Vessel Occlusion: Should Emergency Medical Services Transport to the Nearest Primary Stroke Center or Bypass to a Comprehensive Stroke Center With Endovascular Capabilities? | Stroke | 2016 |
| 25885963 | The Stroke Hyperglycemia Insulin Network Effort (SHINE) trial: an adaptive trial design case study. | Trials | 2015 |
| 26123479 | 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. | Stroke | 2015 |
| 23506245 | The Stroke Hyperglycemia Insulin Network Effort (SHINE) trial protocol: a randomized, blinded, efficacy trial of standard vs. intensive hyperglycemia management in acute stroke. | Int J Stroke | 2014 |
| 25173721 | Readmissions after cardiac surgery: experience of the National Institutes of Health/Canadian Institutes of Health research cardiothoracic surgical trials network. | Ann Thorac Surg | 2014 |
| 24591838 | Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke. | Vasc Health Risk Manag | 2014 |
| 23709701 | Stroke Progress Review Group: looking back and going forward: introduction. | Stroke | 2013 |
| 24499406 | The effect of covariate adjustment for baseline severity in acute stroke clinical trials with responder analysis outcomes. | Trials | 2013 |
| 24029632 | Influence of chronic hyperglycemia on cerebral microvascular remodeling: an in vivo study using perfusion computed tomography in acute ischemic stroke patients. | Stroke | 2013 |
| 22052513 | Ninety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke. | Stroke | 2012 |
| 22994224 | Considering hyperglycemia and thrombolysis in the Stroke Hyperglycemia Insulin Network Effort (SHINE) trial. | Ann N Y Acad Sci | 2012 |
| 22529200 | The Neurology(®) resident & fellow section: 2004-2012. | Neurology | 2012 |
| 22308239 | Standardizing the structure of stroke clinical and epidemiologic research data: the National Institute of Neurological Disorders and Stroke (NINDS) Stroke Common Data Element (CDE) project. | Stroke | 2012 |
| 21680908 | Acute physiology of stroke score. | Stroke | 2011 |
| 21715703 | Symptomatic ICH and outcomes in patients after IV tPA: a business of risk or risky business? | Neurology | 2011 |
| 20065127 | Hospital care for patients experiencing weekend vs weekday stroke: a comparison of quality and aggressiveness of care. | Arch Neurol | 2010 |
| 20437552 | Aggressive glucose control in acute stroke is the answer in the imaging? | Ann Neurol | 2010 |
| 20185783 | Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial. | Stroke | 2010 |
| 19228853 | Clinical and imaging data at 5 days as a surrogate for 90-day outcome in ischemic stroke. | Stroke | 2009 |
| 19834016 | Glucose Regulation in Acute Stroke Patients (GRASP) trial: a randomized pilot trial. | Stroke | 2009 |
| 19423856 | Clinical trials, devices, unproven treatments, and clinical equipoise. | Stroke | 2009 |
| 19443798 | Change in diffusion-weighted imaging infarct volume predicts neurologic outcome at 90 days: results of the Acute Stroke Accurate Prediction (ASAP) trial serial imaging substudy. | Stroke | 2009 |
| 19478212 | Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials. | Stroke | 2009 |
| 19122025 | Levels of evidence: Taking Neurology to the next level. | Neurology | 2009 |
| 18442531 | Statin therapy improves outcomes after valvular heart surgery. | Ann Thorac Surg | 2008 |
| 18525031 | Translating research into treatments. | Neurology | 2008 |
| 18239161 | Prevalence and prognosis of coexistent asymptomatic intracranial stenosis. | Stroke | 2008 |